Erratum: Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast: Erratum.

[This corrects the article DOI: 10.1097/JW9.0000000000000016.].

In the article entitled “Skin eruption involving bilateral breasts following radiation therapy for invasive ductal carcinoma of the left breast” (International Journal of Women’s Dermatology, June 2022, Volume 8, Issue 2), by Belzer et al., the correct answers to the questions were missing and have been provided below.

Chronic radiation dermatitis

Inflammatory breast cancer

Cellulitis

Carcinoma en cuirasse

Radiation-induced morphea (RIM)/LS overlap

What is your diagnosis?

Correct answer: 5. Radiation-induced morphea (RIM)/LS overlap.

A. RIM typically develops during RT

B. RIM is dependent on radiation dose

C. RIM may extend beyond the radiation field

D. RIM is a precursor to angiosarcoma

E. RIM typically demonstrates atypical fibroblasts and vascular

ectasia on pathology

Which of the following statements regarding RIM is true?

Correct answer: C. RIM may extend beyond the radiation field.

A. Ultrasound of the breast

B. Punch biopsy of affected skin

C. Serum anti-nuclear antibody

D. Serum anti-scleroderma-70 (topoisomerase 1) antibody

E. No diagnostic tests indicated

Which of the following diagnostic tests is recommended when evaluating for potential RIM in a woman with a history of breast cancer?

Correct answer: B. Punch biopsy of affected skin.